CooperCompanies Buys Generate Life Sciences for $1.6B

Nov 23

The publicly held healthcare company CooperCompanies has agreed to pay $1.6 billion to acquire Los Angeles-based Generate Life Sciences.

Generate will be incorporated into CooperSurgical, CooperCompanies’ women’s health and fertility division, the firm announced. The deal is expected to close in December, and add to spiking rates of investment in the life sciences sector seen across the country.